Source: International Congress 2019 – Beyond continuous positive airway pressure treatment
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bikov (Manchester, United Kingdom), M. Meszaros (Budapest, Hungary), J. Vestbo (Manchester, United Kingdom), A. Mathioudakis (Manchester, United Kingdom), L. Kunos (Budapest, Hungary). The use of beta-blockers is not associated with increased daytime sleepiness in patients with obstructive sleep apnoea. 4175

Member's Comments

No comment yet.

Related content which might interest you: Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Daytime sleepiness in patients with treated obstructive sleep apnea Source: Eur Respir J 2007; 30: Suppl. 51, 594s Year: 2007 Predictors of residual sleepiness in adequately treated obstructive sleep apnoea patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Diagnosing excessive daytime sleepiness in obstructive sleep apnoea Source: 5th Sleep and Breathing Conference Year: 2019 The frequency of REM related OSA among patients with mild OSA and the relation between apnea and daytime sleepiness among these patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Effects of solriamfetol on real-world driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Long-term efficacy of solriamfetol for excessive sleepiness in narcolepsy or obstructive sleep apnea Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Obesity and daytime somnolence at patients with obstructive sleep apnea and sistemic hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 562s Year: 2002 Daytime sleepiness and quality of life in patients with obstructive sleep apnea Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea Year: 2021 Residual sleepiness in obstructive sleep apnoea: phenotype and related symptoms Source: Eur Respir J 2011; 37: 98-105 Year: 2011 Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Sleep architecture in patients with moderate to severe sleep apnea without daytime sleepiness Source: Annual Congress 2007 - Clinical applications of noninvasive ventilation Year: 2007 Insomnia related to sleep apnoea: effect of long-term auto-adjusting positive airway pressure treatment Source: Eur Respir J 2013; 41: 593-600 Year: 2013 Sleep and daytime sleepiness in upper airway resistance syndrome compared to obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 17: 838-847 Year: 2001 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Determinants of subjective sleepiness in suspected obstructive sleep apnoea Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009